SCHEMBL4228766

SCHEMBL4228766

CCC1CCCCN1N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.39
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
CYP1A2 P05177 1/20 0.34
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
MAPT P10636 1/20 0.33
ALDH1A1 P00352 4/20 0.33
HTT P42858 1/20 0.33
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27479767 0.81 KMT2A (0.38) KMT2APSEN1PSEN2APH1BNCSTN
SCHEMBL27479411 0.80 CYP1A2 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL27461657 0.75 CHRNB2 (0.36) KMT2APSEN1PSEN2APH1BNCSTN
SCHEMBL99816 0.74 KMT2A (0.33) KMT2APSEN1PSEN2APH1BNCSTN
SCHEMBL7274011 0.73
SCHEMBL98601 0.71 PSEN1 (0.32) KMT2APSEN1PSEN2APH1BNCSTN
SCHEMBL27351277 0.70 ALDH1A1 (0.37) KMT2APSEN1PSEN2APH1BNCSTN
SCHEMBL2662411 0.70
SCHEMBL8329095 0.70
SCHEMBL8328456 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2090621-B1 Sound absorbing foam system PREFORM GMBH (DE) 2009-12-23 EP claimed
EP-2090621-A1 Sound absorbing foam system Preform GmbH (DE) 2009-08-19 EP claimed
EP-4453107-A1 MULTILAYER CONSTRUCTION ON METAL SUBSTRATES BASED ON POLYASPARATE COATINGS Covestro Deutschland AG (DE) 2024-10-30 EP disclosed
EP-4359459-A1 COATING AGENTS AND COATINGS THAT ARE OBTAINABLE THEREFROM AND HAVE IMPROVED RESISTANCE TO SOILING AND (SELF-)CLEANING PROPERTIES Covestro Deutschland AG (DE) 2024-05-01 EP disclosed
WO-2023117614-A1 MULTILAYER CONSTRUCTION ON METAL SUBSTRATES BASED ON POLYASPARATE COATINGS COVESTRO DEUTSCHLAND AG (DE) 2023-06-29 WO disclosed
WO-2022268744-A1 COATING AGENTS AND COATINGS THAT ARE OBTAINABLE THEREFROM AND HAVE IMPROVED RESISTANCE TO SOILING AND (SELF-)CLEANING PROPERTIES COVESTRO DEUTSCHLAND AG (DE) 2022-12-29 WO disclosed
US-9938236-B2 Antiviral agents against HBV infection DREXEL UNIVERSITY (US) 2018-04-10 US disclosed
EP-3271411-A1 SILANE GROUPS CONTAINING POLYISOCYANATES BASED ON 1,5-DIISOCYANATOPENTANE Covestro Deutschland AG (DE) 2018-01-24 EP disclosed
WO-2016146474-A1 SILANE GROUPS CONTAINING POLYISOCYANATES BASED ON 1,5-DIISOCYANATOPENTANE COVESTRO DEUTSCHLAND AG (DE) 2016-09-22 WO disclosed
CN-101712746-B Photopolymer composition for optical elements and visual displays BAYER MATERIALSCIENCE AG 2013-02-06 CN disclosed
US-20120219885-A1 NOVEL NON-CRYSTALLIZING METHACRYLATES, PRODUCTION AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-08-30 US disclosed
WO-2002040257-A1 METHOD FOR REPAIRING COMPOSITE ELEMENTS BASF AKTIENGESELLSCHAFT (DE) 2002-05-23 WO disclosed
WO-2002040265-A1 COMPOSITE ELEMENT CONTAINING POLYISOCYANATE POLYADDITION PRODUCTS BASF AKTIENGESELLSCHAFT (DE) 2002-05-23 WO disclosed
EP-1165314-A1 COMPOSITE ELEMENTS CONTAINING POLYISOCYANATE-POLYADDITION PRODUCTS BASF AKTIENGESELLSCHAFT (DE) 2002-01-02 EP disclosed
EP-1094938-A1 COMPOSITE ELEMENTS CONTAINING COMPACT POLYISOCYANATE POLYADDITION PRODUCTS BASF AKTIENGESELLSCHAFT (DE) 2001-05-02 EP disclosed
EP-1093410-A1 COMPOSITE ELEMENTS CONTAINING COMPACT POLYISOCYANATE POLYADDITION PRODUCTS BASF AKTIENGESELLSCHAFT (DE) 2001-04-25 EP disclosed
WO-2000059718-A1 COMPOSITE ELEMENTS CONTAINING POLYISOCYANATE-POLYADDITION PRODUCTS BASF AKTIENGESELLSCHAFT (DE) 2000-10-12 WO disclosed
US-6100308-A COPOLYMERIZING A DI- OR POLYISOCYANATES WITH A POLYETHER POLYOLS BASED ON AROMATIC AMINES WITH CHAIN EXTENDERS AND/OR CROSSLINKERS IN THE PRESENCE OF BLOWING AGENTS TO FORM THE RIGID POLYETHERURETHANE FOAMS; USE AS INSULATION MATERIAL BASF AKTIENGESELLSCHAFT (DE) 2000-08-08 US disclosed
WO-1999064234-A1 COMPOSITE ELEMENTS CONTAINING COMPACT POLYISOCYANATE POLYADDITION PRODUCTS BASF AKTIENGESELLSCHAFT (DE) 1999-12-16 WO disclosed
WO-1999064233-A1 COMPOSITE ELEMENTS CONTAINING COMPACT POLYISOCYANATE POLYADDITION PRODUCTS BASF AKTIENGESELLSCHAFT (DE) 1999-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219885-A1 NOVEL NON-CRYSTALLIZING METHACRYLATES, PRODUCTION AND USE THEREOF MEP1A, MMAB, RHOA KMT2A 1048/4885PSEN1 3846/4885PSEN2 4021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.